Kygevvi (doxecitine and doxribtimine) for thymidine kinase 2 deficiency: a turning point for an ultra-rare mitochondrial disorder
Abstract Purpose Thymidine kinase 2 deficiency (TK2d) is an ultra-rare, autosomal recessive mitochondrial deoxyribonucleic acid (DNA) depletion syndrome. It causes progressive muscle weakness, respiratory failure, and carries high early mortality. Until recently, management was limited to supportive...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer
2026-06-01
|
| Cyfres: | Journal of Rare Diseases |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1007/s44162-026-00209-y |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
